Literature DB >> 7615790

Deficient antigen-presenting cell function in multiple genetic complementation groups of type II bare lymphocyte syndrome.

S Kovats1, G T Nepom, M Coleman, B Nepom, W W Kwok, J S Blum.   

Abstract

The absence of HLA class II gene expression in type II bare lymphocyte syndrome (BLS) results from defective transcriptional activation of class II histocompatibility genes. Genetic studies have revealed that distinct defects in multiple trans-acting factors result in the immunodeficient BLS phenotype. We studied antigen-presenting cell (APC) function in DR-transfected BLS cells derived from multiple complementation groups. Each BLS cell line displayed the same defective APC phenotype: an inability to mediate class II-restricted presentation of exogenous protein antigens, and structurally altered class II alpha beta dimers. Expression of the HLA class II-like genes DMA and DMB, previously implicated in antigen presentation, was reduced or absent in the BLS cells. Fusion of BLS cells with cell line 721.174, which has a genomic deletion of HLA class II genes, coordinately restores class II structural gene and DM gene expression and a wild-type APC phenotype. Thus each of the molecular defects that silences class II structural gene transcription also results in a defective APC phenotype, providing strong evidence for coregulation of these two functionally linked pathways.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615790      PMCID: PMC185191          DOI: 10.1172/JCI118023

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.

Authors:  R D Salter; D N Howell; P Cresswell
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

2.  Analysis of monoclonal antibodies reactive with human class II beta chains by two-dimensional electrophoresis and Western blotting.

Authors:  S F Radka; C E Machamer; P Cresswell
Journal:  Hum Immunol       Date:  1984-07       Impact factor: 2.850

Review 3.  Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class II antigens.

Authors:  R DeMars; C C Chang; S Shaw; P J Reitnauer; P M Sondel
Journal:  Hum Immunol       Date:  1984-10       Impact factor: 2.850

4.  Two populations of Ia-like molecules on a human B cell line.

Authors:  L A Lampson; R Levy
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

5.  A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome.

Authors:  B Lisowska-Grospierre; D J Charron; C de Préval; A Durandy; C Griscelli; B Mach
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

6.  SFR3-DR5, a monoclonal antibody with HLA-DR5 specificity.

Authors:  S F Radka; C Machamer; P Cresswell; D D Kostyu; F E Ward; D B Amos
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

7.  Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction.

Authors:  K C Chin; C Mao; C Skinner; J L Riley; K L Wright; C S Moreno; G R Stark; J M Boss; J P Ting
Journal:  Immunity       Date:  1994-11       Impact factor: 31.745

8.  A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes.

Authors:  C de Préval; B Lisowska-Grospierre; M Loche; C Griscelli; B Mach
Journal:  Nature       Date:  1985 Nov 21-27       Impact factor: 49.962

9.  Direct demonstration of an HLA-DR allotypic determinant on the low molecular weight (beta) subunit using a mouse monoclonal antibody specific for DR3.

Authors:  J P Johnson; T Meo; G Riethmüller; D J Schendel; R Wank
Journal:  J Exp Med       Date:  1982-07-01       Impact factor: 14.307

10.  Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition.

Authors:  J W Kappler; B Skidmore; J White; P Marrack
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  11 in total

1.  MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen.

Authors:  E J Novak; A W Liu; G T Nepom; W W Kwok
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  Attenuation of massive cytokine response to the staphylococcal enterotoxin B superantigen by the innate immunomodulatory protein lactoferrin.

Authors:  J L Hayworth; K J Kasper; M Leon-Ponte; C A Herfst; D Yue; W C Brintnell; D M Mazzuca; D E Heinrichs; E Cairns; J Madrenas; D W Hoskin; J K McCormick; S M M Haeryfar
Journal:  Clin Exp Immunol       Date:  2009-07       Impact factor: 4.330

3.  Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing.

Authors:  R M Hershberg; P E Framson; D H Cho; L Y Lee; S Kovats; J Beitz; J S Blum; G T Nepom
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

4.  Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition.

Authors:  Jason M God; Dan Zhao; Christine A Cameron; Shereen Amria; Jennifer R Bethard; Azizul Haque
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

5.  Reduction of myeloid-derived suppressor cells and lymphoma growth by a natural triterpenoid.

Authors:  Faisal F Y Radwan; Azim Hossain; Jason M God; Nathan Leaphart; Michelle Elvington; Mitzi Nagarkatti; Stephen Tomlinson; Azizul Haque
Journal:  J Cell Biochem       Date:  2015-01       Impact factor: 4.429

6.  Mechanisms regulating enhanced human leukocyte antigen class II-mediated CD4 + T cell recognition of human B-cell lymphoma by resveratrol.

Authors:  Faisal F Y Radwan; Lixia Zhang; Azim Hossain; Bently P Doonan; Jason M God; Azizul Haque
Journal:  Leuk Lymphoma       Date:  2011-10-24

7.  Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes.

Authors:  Q Li; M K Spriggs; S Kovats; S M Turk; M R Comeau; B Nepom; L M Hutt-Fletcher
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

8.  Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401.

Authors:  L S Wicker; S L Chen; G T Nepom; J F Elliott; D C Freed; A Bansal; S Zheng; A Herman; A Lernmark; D M Zaller; L B Peterson; J B Rothbard; R Cummings; P J Whiteley
Journal:  J Clin Invest       Date:  1996-12-01       Impact factor: 14.808

9.  Sculpting MHC class II-restricted self and non-self peptidome by the class I Ag-processing machinery and its impact on Th-cell responses.

Authors:  Charles T Spencer; Srdjan M Dragovic; Stephanie B Conant; Jennifer J Gray; Mu Zheng; Parimal Samir; Xinnan Niu; Magdalini Moutaftsi; Luc Van Kaer; Alessandro Sette; Andrew J Link; Sebastian Joyce
Journal:  Eur J Immunol       Date:  2013-03-05       Impact factor: 5.532

10.  Novel mutants define genes required for the expression of human histocompatibility leukocyte antigen DM: evidence for loci on human chromosome 6p.

Authors:  S P Fling; J Rak; K A Muczynski; B Arp; D Pious
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.